National Development Fund of Taiwan Government
VC Fund
Taipei, Taiwan
National Development Fund of Taiwan Government is a VC fund in Taipei focused on Software and Information Technology. The national development fund is the management unit of the non-business cycle budget fund, which is tasked with grouping. It aims to accelerate the industrial innovation value-added, promote economic transformation and national development, and help china's industrial innovation value-added, research and development and self-owned brands. Thefinancing method or assisting the competent authorities of the central government to handle the relevant plans to complete the purposes specified in article 30 of the "industry innovation ordinance".
- Total investments:
- 60
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries National Development Fund of Taiwan Government invests in
Stages National Development Fund of Taiwan Government invests in
Countries National Development Fund of Taiwan Government invests in
Round sizes
Round size
- Seed
- $400k–$3.1M
- Series A
- $3.1M–$18M
- Series B
- $2.1M–$30M
Investment Focus
Industry
- Software 15 (25%)
- Information Technology 12 (20%)
- Health Care 10 (17%)
- Biotechnology 7 (12%)
- Artificial Intelligence 6 (10%)
Stage
- Seed 23 (38%)
- Series A 14 (23%)
- Venture - Series Unknown 7 (12%)
- Series B 6 (10%)
- Pre-Seed 2 (3%)
Country
- Taiwan 42 (70%)
- United States 4 (7%)
- China 1 (2%)
- Japan 1 (2%)
- Singapore 1 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
H2U
|
Health to U is a provider of digital health and wellbeing platform, focusing on holistic health, sports, and diets. The H2U Digital Health platform is a breakthrough creation, a framework that maximizes the power of data. The service delivers insightful reviews based on the platform’s analyses of data collected from connected products and services,elevating the overall value of each component. Users are able to get their hands on their records anytime at will, allowing them to stay aware and on top of their physiological states, with access to personalized health solutions and products. | $3.1M / Venture - Series Unknown / Mar 31, 2026 | |
CreatorDB
|
At CreatorDB we believe that influencer marketing is the most important advancement in digital advertising since it’s inception. But we also believe that brands aren’t utilizing the full potential of influencer marketing as it can be extremely difficult to nearly impossible to discover the optimal influencers to work with. Then there are severalincreasingly difficult questions for the brand to answer such as, “How do we know the influencer’s following is real?”, “Is the quote they gave us competitive?”, or “How can we engage with this influencer in a way which is natural for their audience?”East West IMG looks to answer these questions and many more by combining large amounts of data we collect ourselves with an internal creative marketing process to make sure the branding can land with the influencer’s audience. Operating since 2019, we’ve continued to evolve to match the needs of our those we work with.We also provide services to brands that only need a portion of what we offer such as influencer data or helping prepare marketing copy for an influencer campaign.The world deserves to hear about your brand so let us help you spread the message. | $4.7M / Series A / Sep 16, 2025 | |
PopChill
|
PopChill generates an online marketplace for second-hand trade, enabling users to share their fashion styles and sell idle items. | $3.1M / Series A / Sep 15, 2025 | |
Taiwan Universe BioMedicine
|
Taiwan Universe BioMedicine represents an innovative platform for developing VLP vaccines targeting enterovirus and influenza. The Bivalent Enterovirus Vaccine targets two strains of enterovirus, while the Seasonal Influenza-like Virus Particle Vaccine mimics surface proteins of seasonal influenza viruses to bolster immunity. | $2M / Seed / Aug 01, 2025 | |
Primo Biotechnology
|
Primo Biotechnology harnesses advanced molecular imaging and radiopharmaceutical science to provide precise clinical information via targeted radiopharmaceuticals. Primo Biotechnology aims to form a patient-centric healthcare model and establish doctor-patient relationships founded on trust towards conveying hope and happiness to all patients. | $7.6M / Series A / Jul 02, 2025 | |
Syncell
|
Syncell is a life science technology company building products for next-generation spatial biology. Its pioneering Microscoop™ technology enables microscopy-guided nanoscale protein "scooping", making unbiased subcellular spatial proteomics discovery feasible for the first time. This technology can be applied to a broad range ofbiological problems to help understand molecular mechanisms, identify novel disease biomarkers, and reveal novel druggable targets. | $25.7M / Series A / Jun 30, 2025 | |
MedicalTek
|
MedicalTek Co., Ltd. (MDTK) strives to excellence in ingenuity and quality and is committed to continue delivering reliable and user friendly solutions to the health and medical industries. The company keep on focusing on the unmet needs that exist in the Minimally Invasive Surgery, to develop and manufacture the products that can be closer to theneeds of surgeons. | $3.7M / Series A / Dec 30, 2024 | |
500net Technology
|
500 Households Technology Co. is focusing on software research and development and system integration, providing intelligent buildings, smart factories, smart parking lots, Internet of Things (IoT), and artificial intelligence (AI) and other related solutions. Its services cover information system platform construction, heterogeneous systemintegration, central monitoring platform, energy management system (EMS), carbon inventory system (ESG), etc. The company also provides technical support such as customized software development, information outsourcing services, cloud technology, and mobile application development. The customer base ranges from small and medium-sized enterprises to international listed companies, and the service performance exceeds 100 enterprises. | $2.1M / Series B / Dec 30, 2024 | |
KKday
|
KKday is an e-commerce travel platform that offers 10,000+ experiences around the world. It provides a wide breadth of experiences, including theme park tickets, cooking classes, multi-day tours, airport transfers, sim cards, and hidden sights off the beaten path. KKday was incorporated in 2014 and is headquartered in T'ai-pei, Taiwan. | $70M / Venture - Series Unknown / Dec 04, 2024 | |
|
PopChill
|
PopChill generates an online marketplace for second-hand trade, enabling users to share their fashion styles and sell idle items. | $3.1M / Seed / May 21, 2024 | |
| See all 60 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does National Development Fund of Taiwan Government invest in?
National Development Fund of Taiwan Government invests primarily in Software, Information Technology and Health Care startups, most often at Seed and Series A stage. Most of the 60 investments tracked by Shizune back companies in Taiwan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is National Development Fund of Taiwan Government's check size?
National Development Fund of Taiwan Government typically joins rounds of $400k–$3.1M at Seed, $3.1M–$18M at Series A and $2.1M–$30M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds National Development Fund of Taiwan Government participates in.
When did National Development Fund of Taiwan Government last invest?
The most recent investment recorded for National Development Fund of Taiwan Government closed in Mar 2026. Shizune tracks 60 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
